Invention Grant
- Patent Title: Cyclic peptide CXCR4 antagonists
- Patent Title (中): 环肽CXCR4拮抗剂
-
Application No.: US12123574Application Date: 2008-05-20
-
Publication No.: US07691813B2Publication Date: 2010-04-06
- Inventor: Wayne David Kohn , Sheng-Bin Peng , Liang Zeng Yan
- Applicant: Wayne David Kohn , Sheng-Bin Peng , Liang Zeng Yan
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Charles E. Cohen; Andrea M. Castetter
- Main IPC: A61K38/12
- IPC: A61K38/12
Abstract:
Provided are lactam-cyclized peptide CXCR4 antagonists useful in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection.
Public/Granted literature
- US20080300177A1 CYCLIC PEPTIDE CXCR4 ANTAGONISTS Public/Granted day:2008-12-04
Information query
IPC分类:
